Novel therapeutic class for insomnia treatment: Dual orexin receptor antagonists - it is worth to prescribe it?

被引:0
|
作者
Nogueira, J. [1 ]
Ribeiro, R. [1 ]
Mendes, S. [1 ]
Gamito, A. [1 ]
机构
[1] Ctr Hosp Setilbal, Psychiat, Setubal, Portugal
关键词
D O I
10.1016/j.euroneuro.2019.09.800
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.765
引用
收藏
页码:S515 / S515
页数:1
相关论文
共 50 条
  • [41] Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia
    St Onge, Erin
    Phillips, Bradley
    Rowe, Casey
    JOURNAL OF PHARMACY TECHNOLOGY, 2022, 38 (05) : 297 - 303
  • [42] Innovations in Insomnia Management: A Review of Current Approaches and Novel Targets Including Orexin Receptor Antagonists
    Patel, Raj
    Quinn, Ryann
    Silver, Jonathan
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (01) : E28 - E35
  • [43] GPCR structure-based drug discovery: Identification of dual orexin antagonists and orexin-1 selective antagonists for the treatment of insomnia and addiction disorders
    Christopher, John A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [44] Orexin receptor antagonists as potential therapeutic targets for the treatment of anxiety and addictive disorders
    Rorick-Kehn, Linda M.
    Adams, Benjamin L.
    Hart, John C.
    Crile, Robert S.
    McKinzie, David L.
    Menezes, Michelle M.
    Marek, Gerard J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (06) : 257A - 257A
  • [45] Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
    Skudlarek, Jason W.
    DiMarco, Christina N.
    Babaoglu, Kerim
    Roecker, Anthony J.
    Bruno, Joseph G.
    Pausch, Mark A.
    O'Brien, Julie A.
    Cabalu, Tamara D.
    Stevens, Joanne
    Brunner, Joseph
    Tannenbaum, Pamela L.
    Wuelfing, W. Peter
    Garson, Susan L.
    Fox, Steven V.
    Savitz, Alan T.
    Harrell, Charles M.
    Gotter, Anthony L.
    Winrow, Christopher J.
    Renger, John J.
    Kuduk, Scott D.
    Coleman, Paul J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1364 - 1370
  • [46] Orexin receptor antagonists: Medicinal chemistry and therapeutic potential
    Roecker, Anthony J.
    Coleman, Paul J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (11) : 977 - 987
  • [47] Suvorexant: A Dual Orexin Receptor Antagonist for the Treatment of Sleep Onset and Sleep Maintenance Insomnia
    Patel, Kunal V.
    Aspesi, Anthony V.
    Evoy, Kirk E.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 477 - 483
  • [48] The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis
    Xue, Tao
    Wu, Xin
    Chen, Shujun
    Yang, Yanbo
    Yan, Zeya
    Song, Zhaoming
    Zhang, Wei
    Zhang, Jianguo
    Chen, Zhouqing
    Wang, Zhong
    SLEEP MEDICINE REVIEWS, 2022, 61
  • [49] A look at the orexin receptor antagonism approach for the treatment of insomnia
    Balasubramaniam, M.
    Farheen, S. A.
    Srinivas, S.
    Tampi, R. R.
    DRUGS OF THE FUTURE, 2019, 44 (07) : 535 - 544
  • [50] New pharmacological strategies for the management of insomnia : Suvorexant, one receptor antagonists orexin
    Salin-Pascual, Rafael J.
    REVISTA MEXICANA DE NEUROCIENCIA, 2016, 17 (06): : 97 - 105